Regulation of histone modifying enzymes by the ubiquitin-proteasome system

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 4, 2014, Pages 694-702

  Zou, Chunbin ^a   Mallampalli, Rama K ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Epigenetic code; Histone modification; Histone post translational modification enzyme; Protein degradation; Transcriptional regulation; Ubiquitin proteasome system

Indexed keywords

1 ACYLGLYCEROPHOSPHOCHOLINE ACYLTRANSFERASE; ACYLTRANSFERASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DNA METHYLTRANSFERASE 1; HISTONE; HISTONE DEACETYLASE 1; PROTEASOME; STEROID RECEPTOR COACTIVATOR 1; UBIQUITIN;

HISTONE MODIFICATION; HUMAN CHROMOSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

EPIGENETIC CODE; HISTONE MODIFICATION; HISTONE POST-TRANSLATIONAL MODIFICATION ENZYME; PROTEIN DEGRADATION; TRANSCRIPTIONAL REGULATION; UBIQUITIN-PROTEASOME SYSTEM;

ACETYLATION; CHROMATIN; EPIGENESIS, GENETIC; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HISTONES; HUMANS; METHYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; UBIQUITIN;

EID: 84893469971     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.12.016     Document Type: Review

References (109)

1. Allis C.D., Berger S.L., Cote J., Dent S., Jenuwien T., Kouzarides T., Pillus L., Reinberg D., Shi Y., Shiekhattar R., Shilatifard A., Workman J., Zhang Y. New nomenclature for chromatin-modifying enzymes. Cell 2007, 131:633-636.
2. Goldberg A.D., Allis C.D., Bernstein E. Epigenetics: a landscape takes shape. Cell 2007, 128:635-638.
3. Kouzarides T. SnapShot: histone-modifying enzymes. Cell 2007, 131:822.
4. Kouzarides T. SnapShot: histone-modifying enzymes. Cell 2007, 128:802.
5. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
6. Sterner D.E., Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 2000, 64:435-459.
7. Glaser K.B., Staver M.J., Waring J.F., Stender J., Ulrich R.G., Davidsen S.K. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol. Cancer Ther. 2003, 2:151-163.
8. Wang H., Huang Z.Q., Xia L., Feng Q., Erdjument-Bromage H., Strahl B.D., Briggs S.D., Allis C.D., Wong J., Tempst P., Zhang Y. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 2001, 293:853-857.
9. Schneider J., Shilatifard A. Histone demethylation by hydroxylation: chemistry in action. ACS Chem. Biol. 2006, 1:75-81.
10. Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A., Reinberg D. Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II. Cell 2006, 125:703-717.
11. Nowak S.J., Corces V.G. Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet. 2004, 20:214-220.
12. Shiio Y., Eisenman R.N. Histone sumoylation is associated with transcriptional repression. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13225-13230.
13. Tanner K.G., Landry J., Sternglanz R., Denu J.M. Silent information regulator 2 family of NAD-dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:14178-14182.
14. Zou C., Ellis B.M., Smith R.M., Chen B.B., Zhao Y., Mallampalli R.K. Acyl-CoA:lysophosphatidylcholine acyltransferase I (Lpcat1) catalyzes histone protein O-palmitoylation to regulate mRNA synthesis. J. Biol. Chem. 2011, 286:28019-28025.
15. Ellis B., Kaercher L., Snavely C., Zhao Y., Zou C. Lipopolysaccharide triggers nuclear import of Lpcat1 to regulate inducible gene expression in lung epithelia. World J. Biol. Chem. 2012, 3:159-166.
16. Unnikrishnan A., Gafken P.R., Tsukiyama T. Dynamic changes in histone acetylation regulate origins of DNA replication. Nat. Struct. Mol. Biol. 2010, 17:430-437.
17. Zee B.M., Young N.L., Garcia B.A. Quantitative proteomic approaches to studying histone modifications. Curr. Chem. Genomics 2011, 5:106-114.
18. Britton L.M., Gonzales-Cope M., Zee B.M., Garcia B.A. Breaking the histone code with quantitative mass spectrometry. Expert Rev. Proteomics 2011, 8:631-643.
19. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 2002, 82:373-428.
20. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 1998, 67:425-479.
21. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 2001, 70:503-533.
22. Scheffner M., Nuber U., Huibregtse J.M. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 1995, 373:81-83.
23. Xu C., Kim N.G., Gumbiner B.M. Regulation of protein stability by GSK3 mediated phosphorylation. Cell Cycle 2009, 8:4032-4039.
24. Yoo S.H., Mohawk J.A., Siepka S.M., Shan Y., Huh S.K., Hong H.K., Kornblum I., Kumar V., Koike N., Xu M., Nussbaum J., Liu X., Chen Z., Chen Z.J., Green C.B., Takahashi J.S. Competing E3 ubiquitin ligases govern circadian periodicity by degradation of CRY in nucleus and cytoplasm. Cell 2013, 152:1091-1105.
25. Ravid T., Hochstrasser M. Diversity of degradation signals in the ubiquitin-proteasome system. Nat. Rev. Mol. Cell Biol. 2008, 9:679-690.
26. Schrader E.K., Harstad K.G., Matouschek A. Targeting proteins for degradation. Nat. Chem. Biol. 2009, 5:815-822.
27. Fuchs S.Y., Spiegelman V.S., Kumar K.G. The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer. Oncogene 2004, 23:2028-2036.
28. Seo E., Kim H., Kim R., Yun S., Kim M., Han J.K., Costantini F., Jho E.H. Multiple isoforms of beta-TrCP display differential activities in the regulation of Wnt signaling. Cell. Signal. 2009, 21:43-51.
29. Wilkinson K.D. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 1997, 11:1245-1256.
30. Kish-Trier E., Hill C.P. Structural biology of the proteasome. Annu. Rev. Biophys. 2013, 42:29-49.
31. Wigley W.C., Fabunmi R.P., Lee M.G., Marino C.R., Muallem S., DeMartino G.N., Thomas P.J. Dynamic association of proteasomal machinery with the centrosome. J. Cell Biol. 1999, 145:481-490.
32. Wojcik C., Yano M., DeMartino G.N. RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis. J. Cell Sci. 2004, 117:281-292.
33. Bingol B., Wang C.F., Arnott D., Cheng D., Peng J., Sheng M. Autophosphorylated CaMKIIalpha acts as a scaffold to recruit proteasomes to dendritic spines. Cell 2010, 140:567-578.
34. Jin Y., Zeng S.X., Lee H., Lu H. MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation. J. Biol. Chem. 2004, 279:20035-20043.
35. Adenuga D., Yao H., March T.H., Seagrave J., Rahman I. Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke. Am. J. Respir. Cell Mol. Biol. 2009, 40:464-473.
36. Esteve P.O., Chin H.G., Benner J., Feehery G.R., Samaranayake M., Horwitz G.A., Jacobsen S.E., Pradhan S. Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:5076-5081.
37. Zou C., Butler P.L., Coon T.A., Smith R.M., Hammen G., Zhao Y., Chen B.B., Mallampalli R.K. LPS impairs phospholipid synthesis by triggering beta-transducin repeat-containing protein (beta-TrCP)-mediated polyubiquitination and degradation of the surfactant enzyme acyl-CoA:lysophosphatidylcholine acyltransferase I (LPCAT1). J. Biol. Chem. 2011, 286:2719-2727.
38. Esteve P.O., Chang Y., Samaranayake M., Upadhyay A.K., Horton J.R., Feehery G.R., Cheng X., Pradhan S. A methylation and phosphorylation switch between an adjacent lysine and serine determines human DNMT1 stability. Nat. Struct. Mol. Biol. 2011, 18:42-48.
39. Gaughan L., Logan I.R., Neal D.E., Robson C.N. Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation. Nucleic Acids Res. 2005, 33:13-26.
40. Ghoshal K., Datta J., Majumder S., Bai S., Kutay H., Motiwala T., Jacob S.T. 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. Mol. Cell. Biol. 2005, 25:4727-4741.
41. Chen J., St-Germain J.R., Li Q. B56 regulatory subunit of protein phosphatase 2A mediates valproic acid-induced p300 degradation. Mol. Cell. Biol. 2005, 25:525-532.
42. Chen J., Li Q. Life and death of transcriptional co-activator p300. Epigenetics 2011, 6:957-961.
43. Poizat C., Puri P.L., Bai Y., Kedes L. Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells. Mol. Cell. Biol. 2005, 25:2673-2687.
44. Zou C., Chen Y., Smith R.M., Snavely C., Li J., Coon T.A., Chen B.B., Zhao Y., Mallampalli R.K. SCFFbxw15 mediates histone acetyltransferase binding to origin recognition complex (HBO1) ubiquitin-proteasomal degradation to regulate cell proliferation. J. Biol. Chem. 2013, 288:6306-6316.
45. Tominaga K., Tominaga E., Ausserlechner M.J., Pereira-Smith O.M. The cell senescence inducing gene product MORF4 is regulated by degradation via the ubiquitin/proteasome pathway. Exp. Cell Res. 2010, 316:92-102.
46. Gondor A., Ohlsson R. Replication timing and epigenetic reprogramming of gene expression: a two-way relationship?. Nat. Rev. Genet. 2009, 10:269-276.
47. Pinheiro I., Margueron R., Shukeir N., Eisold M., Fritzsch C., Richter F.M., Mittler G., Genoud C., Goyama S., Kurokawa M., Son J., Reinberg D., Lachner M., Jenuwein T. Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity. Cell 2012, 150:948-960.
48. Fermento M.E., Gandini N.A., Lang C.A., Perez J.E., Maturi H.V., Curino A.C., Facchinetti M.M. Intracellular distribution of p300 and its differential recruitment to aggresomes in breast cancer. Exp. Mol. Pathol. 2010, 88:256-264.
49. Wu P.Y., Ruhlmann C., Winston F., Schultz P. Molecular architecture of the S. cerevisiae SAGA complex. Mol. Cell 2004, 15:199-208.
50. Sterner D.E., Belotserkovskaya R., Berger S.L. SALSA, a variant of yeast SAGA, contains truncated Spt7, which correlates with activated transcription. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:11622-11627.
51. Horiuchi J., Silverman N., Pina B., Marcus G.A., Guarente L. ADA1, a novel component of the ADA/GCN5 complex, has broader effects than GCN5, ADA2, or ADA3. Mol. Cell. Biol. 1997, 17:3220-3228.
52. Rando O.J., Winston F. Chromatin and transcription in yeast. Genetics 2012, 190:351-387.
53. Brownell J.E., Allis C.D. Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr. Opin. Genet. Dev. 1996, 6:176-184.
54. Grant P.A., Duggan L., Cote J., Roberts S.M., Brownell J.E., Candau R., Ohba R., Owen-Hughes T., Allis C.D., Winston F., Berger S.L., Workman J.L. Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex. Genes Dev. 1997, 11:1640-1650.
55. Imoberdorf R.M., Topalidou I., Strubin M. A role for gcn5-mediated global histone acetylation in transcriptional regulation. Mol. Cell. Biol. 2006, 26:1610-1616.
56. Li Y., Jaramillo-Lambert A.N., Yang Y., Williams R., Lee N.H., Zhu W. And-1 is required for the stability of histone acetyltransferase Gcn5. Oncogene 2012, 31:643-652.
57. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996, 87:953-959.
58. Chan H.M., La Thangue N.B. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 2001, 114:2363-2373.
59. Iyer N.G., Xian J., Chin S.F., Bannister A.J., Daigo Y., Aparicio S., Kouzarides T., Caldas C. p300 is required for orderly G1/S transition in human cancer cells. Oncogene 2007, 26:21-29.
60. Goodman R.H., Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 2000, 14:1553-1577.
61. Iyer N.G., Ozdag H., Caldas C. p300/CBP and cancer. Oncogene 2004, 23:4225-4231.
62. Sen N., Hara M.R., Kornberg M.D., Cascio M.B., Bae B.I., Shahani N., Thomas B., Dawson T.M., Dawson V.L., Snyder S.H., Sawa A. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Nat. Cell Biol. 2008, 10:866-873.
63. Poizat C., Sartorelli V., Chung G., Kloner R.A., Kedes L. Proteasome-mediated degradation of the coactivator p300 impairs cardiac transcription. Mol. Cell. Biol. 2000, 20:8643-8654.
64. Sanchez-Molina S., Oliva J.L., Garcia-Vargas S., Valls E., Rojas J.M., Martinez-Balbas M.A. The histone acetyltransferases CBP/p300 are degraded in NIH 3T3 cells by activation of Ras signalling pathway. Biochem. J. 2006, 398:215-224.
65. Wang Q.E., Han C., Zhao R., Wani G., Zhu Q., Gong L., Battu A., Racoma I., Sharma N., Wani A.A. p38 MAPK- and Akt-mediated p300 phosphorylation regulates its degradation to facilitate nucleotide excision repair. Nucleic Acids Res. 2013, 41:1722-1733.
66. Howie H.L., Koop J.I., Weese J., Robinson K., Wipf G., Kim L., Galloway D.A. Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association. PloS Pathog. 2011, 7:e1002211.
67. Shi D., Pop M.S., Kulikov R., Love I.M., Kung A.L., Grossman S.R. CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:16275-16280.
68. Shima Y., Shima T., Chiba T., Irimura T., Pandolfi P.P., Kitabayashi I. PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation. Mol. Cell. Biol. 2008, 28:7126-7138.
69. Liu Y., Mayo M.W., Nagji A.S., Hall E.H., Shock L.S., Xiao A., Stelow E.B., Jones D.R. BRMS1 suppresses lung cancer metastases through an E3 ligase function on histone acetyltransferase p300. Cancer Res. 2013, 73:1308-1317.
70. St-Germain J.R., Chen J., Li Q. Involvement of PML nuclear bodies in CBP degradation through the ubiquitin-proteasome pathway. Epigenetics 2008, 3:342-349.
71. Blanco J.C., Minucci S., Lu J., Yang X.J., Walker K.K., Chen H., Evans R.M., Nakatani Y., Ozato K. The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev. 1998, 12:1638-1651.
72. Miotto B., Struhl K. HBO1 histone acetylase is a coactivator of the replication licensing factor Cdt1. Genes Dev. 2008, 22:2633-2638.
73. Miotto B., Struhl K. JNK1 phosphorylation of Cdt1 inhibits recruitment of HBO1 histone acetylase and blocks replication licensing in response to stress. Mol. Cell 2011, 44:62-71.
74. Miotto B. Regulation of DNA licensing by targeted chromatin remodeling. Cell Cycle 2011, 10:1522.
75. Hung T., Binda O., Champagne K.S., Kuo A.J., Johnson K., Chang H.Y., Simon M.D., Kutateladze T.G., Gozani O. ING4 mediates crosstalk between histone H3 K4 trimethylation and H3 acetylation to attenuate cellular transformation. Mol. Cell 2009, 33:248-256.
76. Bertram M.J., Pereira-Smith O.M. Conservation of the MORF4 related gene family: identification of a new chromo domain subfamily and novel protein motif. Gene 2001, 266:111-121.
77. Bryce S.D., Forsyth N.R., Fitzsimmons S.A., Clark L.J., Bertram M.J., Cuthbert A.P., Newbold R.F., Pereira-Smith O.M., Parkinson E.K. Genetic and functional analyses exclude mortality factor 4 (MORF4) as a keratinocyte senescence gene. Cancer Res. 1999, 59:2038-2040.
78. Chen M., Takano-Maruyama M., Pereira-Smith O.M., Gaufo G.O., Tominaga K. MRG15, a component of HAT and HDAC complexes, is essential for proliferation and differentiation of neural precursor cells. J. Neurosci. Res. 2009, 87:1522-1531.
79. Garcia S.N., Kirtane B.M., Podlutsky A.J., Pereira-Smith O.M., Tominaga K. Mrg15 null and heterozygous mouse embryonic fibroblasts exhibit DNA-repair defects post exposure to gamma ionizing radiation. FEBS Lett. 2007, 581:5275-5281.
80. Pena A.N., Pereira-Smith O.M. The role of the MORF/MRG family of genes in cell growth, differentiation, DNA repair, and thereby aging. Ann. N. Y. Acad. Sci. 2007, 1100:299-305.
81. Martrat G., Maxwell C.M., Tominaga E., Porta-de-la-Riva M., Bonifaci N., Gomez-Baldo L., Bogliolo M., Lazaro C., Blanco I., Brunet J., Aguilar H., Fernandez-Rodriguez J., Seal S., Renwick A., Rahman N., Kuhl J., Neveling K., Schindler D., Ramirez M.J., Castella M., Hernandez G., Embrace, Easton D.F., Peock S., Cook M., Oliver C.T., Frost D., Platte R., Evans D.G., Lalloo F., Eeles R., Izatt L., Chu C., Davidson R., Ong K.R., Cook J., Douglas F., Hodgson S., Brewer C., Morrison P.J., Porteous M., Peterlongo P., Manoukian S., Peissel B., Zaffaroni D., Roversi G., Barile M., Viel A., Pasini B., Ottini L., Putignano A.L., Savarese A., Bernard L., Radice P., Healey S., Spurdle A., Chen X., Beesley J., kConFab, Rookus M.A., Verhoef S., Tilanus-Linthorst M.A., Vreeswijk M.P., Asperen C.J., Bodmer D., Ausems M.G., van Os T.A., Blok M.J., Meijers-Heijboer H.E., Hogervorst F.B., Hebon, Goldgar D.E., Buys S., John E.M., Miron A., Southey M., Daly M.B., Bcfr, B.Swe, Harbst K., Borg A., Rantala J., Barbany-Bustinza G., Ehrencrona H., Stenmark-Askmalm M., Kaufman B., Laitman Y., Milgrom R., Friedman E., Domchek S.M., Nathanson K.L., Rebbeck T.R., Johannsson O.T., Couch F.J., Wang X., Fredericksen Z., Cuadras D., Moreno V., Pientka F.K., Depping R., Caldes T., Osorio A., Benitez J., Bueren J., Heikkinen T., Nevanlinna H., Hamann U., Torres D., Caligo M.A., Godwin A.K., Imyanitov E.N., Janavicius R., G.S.Collaborators, Sinilnikova O.M., Stoppa-Lyonnet D., Mazoyer S., Verny-Pierre C., Castera L., de Pauw A., Bignon Y.J., Uhrhammer N., Peyrat J.P., Vennin P., Ferrer S.F., Collonge-Rame M.A., Mortemousque I., McGuffog L., Chenevix-Trench G., Pereira-Smith O.M., Antoniou A.C., Ceron J., Tominaga K., Surralles J., Pujana M.A. Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Res. 2011, 13:R40.
82. C.Coronary Artery Disease Genetics A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat. Genet. 2011, 43:339-344.
83. Jones J., Wu K., Yang Y., Guerrero C., Nillegoda N., Pan Z.Q., Huang L. A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins. J. Proteome Res. 2008, 7:1274-1287.
84. Spencer T.E., Jenster G., Burcin M.M., Allis C.D., Zhou J., Mizzen C.A., McKenna N.J., Onate S.A., Tsai S.Y., Tsai M.J., O'Malley B.W. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 1997, 389:194-198.
85. Onate S.A., Boonyaratanakornkit V., Spencer T.E., Tsai S.Y., Tsai M.J., Edwards D.P., O'Malley B.W. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J. Biol. Chem. 1998, 273:12101-12108.
86. Sheppard H.M., Harries J.C., Hussain S., Bevan C., Heery D.M. Analysis of the steroid receptor coactivator 1 (SRC1)-CREB binding protein interaction interface and its importance for the function of SRC1. Mol. Cell. Biol. 2001, 21:39-50.
87. Amazit L., Roseau A., Khan J.A., Chauchereau A., Tyagi R.K., Loosfelt H., Leclerc P., Lombes M., Guiochon-Mantel A. Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity. Mol. Endocrinol. 2011, 25:394-408.
88. Wolffe A.P. Histone deacetylase: a regulator of transcription. Science 1996, 272:371-372.
89. Taunton J., Hassig C.A., Schreiber S.L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 1996, 272:408-411.
90. Aapola U., Liiv I., Peterson P. Imprinting regulator DNMT3L is a transcriptional repressor associated with histone deacetylase activity. Nucleic Acids Res. 2002, 30:3602-3608.
91. Cai R.L., Yan-Neale Y., Cueto M.A., Xu H., Cohen D. HDAC1, a histone deacetylase, forms a complex with Hus1 and Rad9, two G2/M checkpoint Rad proteins. J. Biol. Chem. 2000, 275:27909-27916.
92. Drummond D.C., Noble C.O., Kirpotin D.B., Guo Z., Scott G.K., Benz C.C. Clinical development of histone deacetylase inhibitors as anticancer agents. Annu. Rev. Pharmacol. Toxicol. 2005, 45:495-528.
93. Ahringer J. NuRD and SIN3 histone deacetylase complexes in development. Trends Genet. 2000, 16:351-356.
94. Zhang Y., Iratni R., Erdjument-Bromage H., Tempst P., Reinberg D. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 1997, 89:357-364.
95. Zhang Y., Sun Z.W., Iratni R., Erdjument-Bromage H., Tempst P., Hampsey M., Reinberg D. SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex. Mol. Cell 1998, 1:1021-1031.
96. Zhang Y., LeRoy G., Seelig H.P., Lane W.S., Reinberg D. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 1998, 95:279-289.
97. Tong J.K., Hassig C.A., Schnitzler G.R., Kingston R.E., Schreiber S.L. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 1998, 395:917-921.
98. Xue Y., Wong J., Moreno G.T., Young M.K., Cote J., Wang W. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol. Cell 1998, 2:851-861.
99. Oh Y.M., Kwon Y.E., Kim J.M., Bae S.J., Lee B.K., Yoo S.J., Chung C.H., Deshaies R.J., Seol J.H. Chfr is linked to tumour metastasis through the downregulation of HDAC1. Nat. Cell Biol. 2009, 11:295-302.
100. Kramer O.H., Zhu P., Ostendorff H.P., Golebiewski M., Tiefenbach J., Peters M.A., Brill B., Groner B., Bach I., Heinzel T., Gottlicher M. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J. 2003, 22:3411-3420.
101. Yen R.W., Vertino P.M., Nelkin B.D., Yu J.J., el-Deiry W., Cumaraswamy A., Lennon G.G., Trask B.J., Celano P., Baylin S.B. Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res. 1992, 20:2287-2291.
102. Rountree M.R., Bachman K.E., Baylin S.B. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet. 2000, 25:269-277.
103. Iida T., Suetake I., Tajima S., Morioka H., Ohta S., Obuse C., Tsurimoto T. PCNA clamp facilitates action of DNA cytosine methyltransferase 1 on hemimethylated DNA. Genes Cells 2002, 7:997-1007.
104. Tatematsu K.I., Yamazaki T., Ishikawa F. MBD2-MBD3 complex binds to hemi-methylated DNA and forms a complex containing DNMT1 at the replication foci in late S phase. Genes Cells 2000, 5:677-688.
105. Jair K.W., Bachman K.E., Suzuki H., Ting A.H., Rhee I., Yen R.W., Baylin S.B., Schuebel K.E. De novo CpG island methylation in human cancer cells. Cancer Res. 2006, 66:682-692.
106. Patel K., Dickson J., Din S., Macleod K., Jodrell D., Ramsahoye B. Targeting of 5-aza-2'-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme. Nucleic Acids Res. 2010, 38:4313-4324.
107. Nakanishi H., Shindou H., Hishikawa D., Harayama T., Ogasawara R., Suwabe A., Taguchi R., Shimizu T. Cloning and characterization of mouse lung-type acyl-CoA:lysophosphatidylcholine acyltransferase 1 (LPCAT1). Expression in alveolar type II cells and possible involvement in surfactant production. J. Biol. Chem. 2006, 281:20140-20147.
108. Bridges J.P., Ikegami M., Brilli L.L., Chen X., Mason R.J., Shannon J.M. LPCAT1 regulates surfactant phospholipid synthesis and is required for transitioning to air breathing in mice. J. Clin. Invest. 2010, 120:1736-1748.
109. Weathington N.M., Mallampalli R.K. Emerging therapies targeting the ubiquitin proteasome system in cancer. J. Clin. Invest. 2014, 124:6-12.